Nociceptin differentially affects morphine-induced dopamine release from the nucleus accumbens and nucleus caudate in rats

[1]  A. Loizzo,et al.  Orphanin FQ reduces morphine-induced dopamine release in the nucleus accumbens: a microdialysis study in rats , 1999, Neuroscience Letters.

[2]  N. Maidment,et al.  Orphanin FQ/Nociceptin Modulation of Mesolimbic Dopamine Transmission Determined by Microdialysis , 1999, Journal of neurochemistry.

[3]  N. Maidment,et al.  Orphanin FQ/nociceptin blocks acquisition of morphine place preference , 1999, Brain Research.

[4]  N. Koshikawa,et al.  Fentanyl increases dopamine release in rat nucleus accumbens: involvement of mesolimbic mu- and delta-2-opioid receptors , 1999, Neuroscience.

[5]  M. Kathmann,et al.  Further characterization of the ORL1 receptor‐mediated inhibition of noradrenaline release in the mouse brain in vitro , 1999, British journal of pharmacology.

[6]  C. Polidori,et al.  Effect of nociceptin on alcohol intake in alcohol-preferring rats , 1999, Psychopharmacology.

[7]  M. Kathmann,et al.  Nociceptin inhibits noradrenaline release in the mouse brain cortex via presynaptic ORL1 receptors , 1998, Naunyn-Schmiedeberg's Archives of Pharmacology.

[8]  P. Enrico,et al.  Effect of naloxone on morphine-induced changes in striatal dopamine metabolism and glutamate, ascorbic acid and uric acid release in freely moving rats , 1998, Brain Research.

[9]  H. Masuda,et al.  Modification of dopamine release by nociceptin in conscious rat striatum , 1998, Brain Research.

[10]  G. Chiara.  A motivational learning hypothesis of the role of mesolimbic dopamine in compulsive drug use , 1998 .

[11]  F. Monsma,et al.  Orphanin FQ acts as an anxiolytic to attenuate behavioral responses to stress. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[12]  G. Henderson,et al.  The orphan opioid receptor and its endogenous ligand--nociceptin/orphanin FQ. , 1997, Trends in pharmacological sciences.

[13]  E. Pintér,et al.  Inhibition by nociceptin of neurogenic inflammation and the release of SP and CGRP from sensory nerve terminals , 1997, British journal of pharmacology.

[14]  G. Pasternak,et al.  G proteins and opioid receptor-mediated signalling. , 1997, Cellular signalling.

[15]  M. Neal,et al.  Inhibition by nociceptin of the light‐evoked release of ACh from retinal cholinergic neurones , 1997, British journal of pharmacology.

[16]  H. Champion,et al.  Nociceptin, an endogenous ligand for the ORL1 receptor, has novel hypotensive activity in the rat. , 1997, Life sciences.

[17]  M. Christie,et al.  Actions of the ORL1 Receptor Ligand Nociceptin on Membrane Properties of Rat Periaqueductal Gray Neurons In Vitro , 1997, The Journal of Neuroscience.

[18]  M. Belvisi,et al.  Naloxone‐insensitive inhibition of acetylcholine release from parasympathetic nerves innervating guinea‐pig trachea by the novel opioid, nociceptin , 1997, British journal of pharmacology.

[19]  L. Terenius,et al.  Nociceptin/Orphanin FQ Microinjected into Hippocampus Impairs Spatial Learning in Rats , 1997, The European journal of neuroscience.

[20]  C. Evans,et al.  Orphanin FQ inhibits synaptic transmission and long‐term potentiation in rat hippocampus , 1997, Hippocampus.

[21]  M. Nishi,et al.  Identification and characterization of an endogenous ligand for opioid receptor homologue ROR-C: its involvement in allodynic response to innocuous stimulus. , 1996, Brain research. Molecular brain research.

[22]  A. Levine,et al.  Orphanin FQ, agonist of orphan opioid receptor ORL1, stimulates feeding in rats , 1996, Neuroreport.

[23]  B. Chieng,et al.  Nociceptin receptor coupling to a potassium conductance in rat locus coeruleus neurones in vitro , 1996, British journal of pharmacology.

[24]  J. Kemp,et al.  Modulation of Voltage-Gated Calcium Channels by Orphanin FQ in Freshly Dissociated Hippocampal Neurons , 1996, The Journal of Neuroscience.

[25]  D. Grandy,et al.  Orphanin FQ is a functional anti-opioid peptide , 1996, Neuroscience.

[26]  N. Maidment,et al.  Intracerebroventricular orphanin FQ/Nociceptin supresses dopamine release in the nucleus accumbens of anaesthetized rats , 1996, Neuroscience.

[27]  D. Grandy,et al.  Functional antagonism of μ-, δ- and κ-opioid antinociception by orphanin FQ , 1996, Neuroscience Letters.

[28]  M. Connor,et al.  The effect of nociceptin on Ca2+ channel current and intracellular Ca2+ in the SH‐SY5Y human neuroblastoma cell line , 1996, British journal of pharmacology.

[29]  B Anton,et al.  Immunohistochemical localization of ORL‐1 in the central nervous system of the rat , 1996, The Journal of comparative neurology.

[30]  M. Christie,et al.  Increase by the ORL1 receptor (opioid receptor‐like1) ligand, nociceptin, of inwardly rectifying K conductance in dorsal raphe nucleus neurones , 1996, British journal of pharmacology.

[31]  D. Grandy,et al.  Orphanin FQ: A Neuropeptide That Activates an Opioidlike G Protein-Coupled Receptor , 1995, Science.

[32]  Marc Parmentier,et al.  Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor , 1995, Nature.

[33]  M. Caporali,et al.  Simultaneous high-performance liquid chromatographic determination of adenosine and dopamine in rat striatal tissue with combined ultraviolet absorbance and electrochemical detection. , 1994, Journal of chromatography. B, Biomedical applications.

[34]  P. Zaratin,et al.  Comparative effects of selective kappa-opioid receptor agonists on dopamine levels in the dorsal caudate of freely moving rats. , 1994, European journal of pharmacology.

[35]  M. Mortrud,et al.  Molecular cloning and tissue distribution of a putative member of the rat opioid receptor gene family that is not a μ, δ or κ opioid receptor type , 1994 .

[36]  S. Grant,et al.  Buprenorphine and morphine produce equivalent increases in extracellular single unit activity of dopamine neurons in the ventral tegrnental area in vivo , 1994, Synapse.

[37]  R. Wise,et al.  Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis studies. , 1993, The Journal of pharmacology and experimental therapeutics.

[38]  P. Wood.  Interrelationships of Opioid, Dopaminergic, Cholinergic, and GABAergic Pathways in the Central Nervous System , 1993 .

[39]  P. Kalivas,et al.  Regulation of somatodendritic dopamine release in the ventral tegmental area by opioids and GABA: an in vivo microdialysis study , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[40]  Rainer Spanagel,et al.  Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway , 1992 .

[41]  R. North,et al.  Opioids excite dopamine neurons by hyperpolarization of local interneurons , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[42]  R. Spanagel,et al.  Identification of the opioid receptor types mediating beta-endorphin-induced alterations in dopamine release in the nucleus accumbens. , 1990, European journal of pharmacology.

[43]  R. Spanagel,et al.  The Effects of Opioid Peptides on Dopamine Release in the Nucleus Accumbens: An In Vivo Microdialysis Study , 1990, Journal of neurochemistry.

[44]  T. Shippenberg,et al.  Neurochemical Aspects of Addiction: Opioids and Other Drugs of Abuse , 1989 .

[45]  A. Goldstein.  Molecular and Cellular Aspects of the Drug Addictions , 1989, Springer New York.

[46]  G. Di Chiara,et al.  Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats. , 1988, The Journal of pharmacology and experimental therapeutics.

[47]  D. German,et al.  Electrophysiological evidence for excitation of rat ventral tegmental area dopamine neurons by morphine , 1984, Neuroscience.

[48]  K. Gysling,et al.  Morphine-induced activation of A10 dopamine neurons in the rat , 1983, Brain Research.

[49]  K. Iwatsubo,et al.  Effects of morphine and haloperidol on the electrical activity of rat nigrostriatal neurons. , 1977, The Journal of pharmacology and experimental therapeutics.